|
271 Companies |
|
374 Products |
|
374 Products |
|
160 Mechanisms of Action |
|
34 Trials |
|
5514 News |
|
| «12...2829303132333435363738...110111» |
- Trial primary completion date: Validity of Patient-Collected Wet Mounts (clinicaltrials.gov) - Apr 8, 2016
P=N/A, N=40, Recruiting, Sponsor: The University of Texas Health Science Center at San Antonio
Trial primary completion date: Jan 2016 --> Jul 2016
- Follistim AQ Cartridge (follitropin beta) / Organon
Trial primary completion date: Addition of Prednisolone and Heparin in Patients Undergoing IVF With Failed IVF Cycles (clinicaltrials.gov) - Apr 8, 2016
P2/3, N=200, Recruiting, Sponsor: National and Kapodistrian University of Athens
Trial primary completion date: Jan 2016 --> Jul 2016 Trial primary completion date: Dec 2015 --> Jun 2016
- Preclinical, Enrollment change, Trial primary completion date: Role of Heparin in Poor Responders Undergoing In Vitro Fertilisation (clinicaltrials.gov) - Apr 8, 2016
P2/3, N=50, Recruiting, Sponsor: National and Kapodistrian University of Athens
Trial primary completion date: Dec 2015 --> Jun 2016 N=100 --> 50 | Trial primary completion date: Dec 2015 --> Jun 2016
- azithromycin / Generic mfg.
Trial primary completion date: C/SOAP: Study of Effectiveness and Safety of Azithromycin-based Extended-spectrum Prophylaxis to Prevent Post Cesarean Infection (clinicaltrials.gov) - Apr 7, 2016
P=N/A, N=2013, Completed, Sponsor: Alan Tita
N=100 --> 50 | Trial primary completion date: Dec 2015 --> Jun 2016 Trial primary completion date: Feb 2015 --> Dec 2015
- Trial completion, Enrollment change: Automated 3D (SonoAVC) Versus 2D Ovarian Follicles Assessment in IVF Cycles: a Randomized Controlled Trial (clinicaltrials.gov) - Apr 7, 2016
P=N/A, N=54, Completed, Sponsor: Rabin Medical Center
Trial primary completion date: Feb 2015 --> Dec 2015 Not yet recruiting --> Completed | N=100 --> 54
- Trial primary completion date: Choline Dehydrogenase and Sperm Function: Effects of Betaine (clinicaltrials.gov) - Apr 7, 2016
P1, N=15, Recruiting, Sponsor: University of North Carolina, Chapel Hill
Not yet recruiting --> Completed | N=100 --> 54 Trial primary completion date: Feb 2016 --> Jul 2016
- Trial completion, Head-to-Head: A Non-inferiority Randomized Controlled Trial to Evaluate Promoting Condom Use Among MSM and Transgender Individuals in China (clinicaltrials.gov) - Apr 7, 2016
P=N/A, N=1173, Completed, Sponsor: University of North Carolina, Chapel Hill
Trial primary completion date: Feb 2016 --> Jul 2016 Active, not recruiting --> Completed
- ||| RG 7600 / Roche
Trial completion: A Study of DMOT4039A in Participants With Unresectable Pancreatic or Platinum-Resistant Ovarian Cancer (clinicaltrials.gov) - Apr 7, 2016
P1, N=71, Completed, Sponsor: Genentech, Inc.
Active, not recruiting --> Completed Active, not recruiting --> Completed
- Trial primary completion date: Study of Electro-kinetically Modified Water for the Treatment of Pain Associated With Endometriosis (clinicaltrials.gov) - Apr 7, 2016
P=N/A, N=40, Recruiting, Sponsor: Revalesio Corporation
Active, not recruiting --> Completed Trial primary completion date: Aug 2016 --> Dec 2016
- || New P3 trial: Chemotherapy vs Hormonal Treatment in Platinum-resistant Ovarian Cancer Resistant or Refractory to Platinum and Taxane (clinicaltrials.gov) - Apr 6, 2016
P3, N=241, Completed, Sponsor: Nordic Society for Gynaecologic Oncology
- Biomarker, New trial, IO biomarker: Standard Operating Procedures for Cervical (Pre)Cancer Biomarker Detection in First-void Urine (BM-SOP Study) (clinicaltrials.gov) - Apr 6, 2016
P=N/A, N=100, Recruiting, Sponsor: Universiteit Antwerpen
- | Visanne (dienogest) / Mochida, Bayer
New P2 trial, Surgery: DOROSY: Trial Comparing Preoperative Dienogest Therapy Followed by Surgery vs. Upfront Surgery to Save Ovarian Reserve in Young Women With Ovarian Endometrioma (clinicaltrials.gov) - Apr 6, 2016
P2, N=72, Not yet recruiting, Sponsor: Seoul National University Hospital
- quisinostat (JNJ 26481585) / ChemRar, Viriom
New P1 trial, Combination therapy, Epigenetic controller: Safety, Tolerability and Pharmacokinetics of Quisinostat, a Histone Deacetylase Inhibitor, in Combination With Chemotherapy (clinicaltrials.gov) - Apr 6, 2016
P1, N=51, Completed, Sponsor: NewVac LLC
- New P3 trial: ULMOST: Ultrasonic Versus Monopolar Energy-based Surgical Device in Colpotomy (clinicaltrials.gov) - Apr 6, 2016
P3, N=40, Not yet recruiting, Sponsor: Kangbuk Samsung Hospital
- New P1 trial: COMPRIGEL: Study Evaluating the Optimal Dosage for Equivalence Between Lcr Regenerans® Capsules and Tablets (Lactobacillus Rhamnosus Lcr35®) on the Vaginal Flora Colonisation (clinicaltrials.gov) - Apr 6, 2016
P1, N=34, Completed, Sponsor: Biose
- Trial primary completion date: MANI-PCOS: Mood and Nutrition Interventions in Polycystic Ovary Syndrome (clinicaltrials.gov) - Apr 4, 2016
P=N/A, N=50, Recruiting, Sponsor: University of Pennsylvania
Trial primary completion date: Aug 2016 --> Dec 2016 Trial primary completion date: Nov 2015 --> Aug 2016
- New trial, Preclinical: Mitenergy: Mitochondrial Energy Production in ART (Assisted Reproductive Technology ) (clinicaltrials.gov) - Apr 4, 2016
P=N/A, N=60, Not yet recruiting, Sponsor: IVI Madrid
- Korlym (mifepristone) / Corcept Therap
Trial primary completion date, Combination therapy, Metastases: Mifepristone and Eribulin in Patients With Metastatic Triple Negative Breast Cancer or Other Specified Solid Tumors (clinicaltrials.gov) - Apr 4, 2016
P1, N=40, Recruiting, Sponsor: Corcept Therapeutics
Trial primary completion date: Nov 2015 --> Aug 2016 Trial primary completion date: Jan 2016 --> Jun 2016
- | New P1/2 trial: Comparison of Different Doses of Oestrogen Therapy for Preventing Intrauterine Adhesion (clinicaltrials.gov) - Apr 4, 2016
P1/2, N=150, Recruiting, Sponsor: Fu Xing Hospital, Capital Medical University
- Trial primary completion date: Microfinance and Health Intervention Trial for Youth in Dar es Salaam, Tanzania (clinicaltrials.gov) - Apr 1, 2016
P=N/A, N=2623, Active, not recruiting, Sponsor: University of North Carolina, Chapel Hill
Trial primary completion date: Jan 2016 --> Jun 2016 Trial primary completion date: Apr 2016 --> Sep 2016
- New trial: Hyaluronan-enriched Embryo Transfer Medium for Frozen-thawed Embryo Transfer (clinicaltrials.gov) - Apr 1, 2016
P=N/A, N=550, Not yet recruiting, Sponsor: The University of Hong Kong
- Mifeprex (mifepristone) / Danco Laboratories
Enrollment open, Metastases: Carboplatin, Gemcitabine Hydrochloride, and Mifepristone in Treating Patients With Advanced Breast Cancer or Recurrent or Persistent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer (clinicaltrials.gov) - Apr 1, 2016
P1, N=22, Recruiting, Sponsor: University of Chicago
Trial primary completion date: Apr 2016 --> Sep 2016 Active, not recruiting --> Recruiting
- ONT-10 / Seagen
Trial primary completion date, Metastases: Study of ONT-10 and Varlilumab to Treat Advanced Ovarian or Breast Cancer (clinicaltrials.gov) - Mar 31, 2016
P1, N=42, Active, not recruiting, Sponsor: Oncothyreon Inc.
Active, not recruiting --> Recruiting Trial primary completion date: Nov 2015 --> Dec 2016
- Trial completion: Prediction of Clinical Response and Outcome in Uterine Cervix Cancer (clinicaltrials.gov) - Mar 30, 2016
P=N/A, N=100, Completed, Sponsor: Maastricht Radiation Oncology
Trial primary completion date: Nov 2015 --> Dec 2016 Recruiting --> Completed
- Zyclara (imiquimod) / Mochida, Viatris, Bausch Health
Trial primary completion date: Topical Imiquimod in Treating Patients With Recurrent Paget's Disease of the Vulva (clinicaltrials.gov) - Mar 29, 2016
P=N/A, N=8, Active, not recruiting, Sponsor: Memorial Sloan Kettering Cancer Center
Recruiting --> Completed Trial primary completion date: Apr 2016 --> Apr 2017
- Enrollment open: CHOiCE: Self-sampling for Non-participants in an Organised Cervical Cancer Screening Programme (clinicaltrials.gov) - Mar 29, 2016
P=N/A, N=9327, Recruiting, Sponsor: University of Aarhus
Trial primary completion date: Apr 2016 --> Apr 2017 Not yet recruiting --> Recruiting
- ||| Enrollment open: Use of a Patient Education/Messaging Platform to Increase Uptake and Series Completion of the HPV Vaccine (clinicaltrials.gov) - Mar 29, 2016
P0, N=598, Recruiting, Sponsor: Regenstrief Institute, Inc.
Not yet recruiting --> Recruiting Not yet recruiting --> Recruiting
- Trial completion, Trial primary completion date: WHC+ (Women's Health CoOp PLUS) (clinicaltrials.gov) - Mar 28, 2016
P1, N=641, Completed, Sponsor: RTI International
Not yet recruiting --> Recruiting Active, not recruiting --> Completed | Trial primary completion date: Apr 2016 --> Dec 2015
- Trial completion, Trial primary completion date: Early Detection of Ovarian Cancer: GC/FT-ICR Mass Spectrometry and Canine Olfaction (clinicaltrials.gov) - Mar 27, 2016
P=N/A, N=109, Completed, Sponsor: Pine Street Foundation
Active, not recruiting --> Completed | Trial primary completion date: Apr 2016 --> Dec 2015 Recruiting --> Completed | Trial primary completion date: Dec 2009 --> Dec 2012
- || Yondelis (trabectedin) / Otsuka, PharmaMar, Valeo Pharma
Enrollment closed, Trial primary completion date: NIS-OvaYond: An Observational Study of YONDELIS®+PLD for the Treatment of Patients With Platinum-sensitive Relapse of Ovarian Cancer (clinicaltrials.gov) - Mar 25, 2016
P=N/A, N=180, Active, not recruiting, Sponsor: PharmaMar, Spain
Recruiting --> Completed | Trial primary completion date: Dec 2009 --> Dec 2012 Recruiting --> Active, not recruiting | Trial primary completion date: Feb 2016 --> Dec 2016
- ||||||| Trial completion, Trial primary completion date, Head-to-Head: GYNOCANS: Study of the Efficacy and Tolerance of Intra-vaginal Treatment With a Total Freeze-dried Culture of Lcr Regenerans® in the Prevention of Relapses of Recurrent Vulvovaginal Candidiasis (clinicaltrials.gov) - Mar 25, 2016
P3, N=350, Completed, Sponsor: Probionov
Recruiting --> Active, not recruiting | Trial primary completion date: Feb 2016 --> Dec 2016 Active, not recruiting --> Completed | Trial primary completion date: May 2014 --> Feb 2016
- New trial: Fast Versus Slow Tenaculum Placement (clinicaltrials.gov) - Mar 23, 2016
P=N/A, N=100, Not yet recruiting, Sponsor: University of Iowa
- || Trial primary completion date: Probe-based and Needle-based Confocal Laser Endomicroscopy During Gynaecological Procedures. (clinicaltrials.gov) - Mar 23, 2016
P=N/A, N=75, Recruiting, Sponsor: Mauna Kea Technologies
Active, not recruiting --> Completed | Trial primary completion date: May 2014 --> Feb 2016 Trial primary completion date: Dec 2015 --> Apr 2016
- estradiol valerate / Generic mfg.
Trial completion, Preclinical, Trial initiation date, Trial primary completion date: Oral Estradiol Valerate Versus Oral Contraceptive Pill in Invitro Fertilization Patients (clinicaltrials.gov) - Mar 23, 2016
P4, N=118, Completed, Sponsor: IVI Madrid
Trial primary completion date: Dec 2015 --> Apr 2016 Recruiting --> Completed | Initiation date: Jun 2011 --> Jan 2012 | Trial primary completion date: Jan 2012 --> May 2012
- Trial primary completion date: Taking Care of Her Program in Patients With Stage III or IV Ovarian Cancer and Spouse Caregivers (clinicaltrials.gov) - Mar 22, 2016
P=N/A, N=64, Recruiting, Sponsor: University of Washington
Recruiting --> Completed | Initiation date: Jun 2011 --> Jan 2012 | Trial primary completion date: Jan 2012 --> May 2012 Trial primary completion date: Aug 2016 --> Feb 2017
- Enrollment closed, Enrollment change, Trial primary completion date: Reducing HIV Risk Among Adolescents: Evaluating Project HEART (clinicaltrials.gov) - Mar 22, 2016
P=N/A, N=222, Active, not recruiting, Sponsor: North Carolina State University
Trial primary completion date: Aug 2016 --> Feb 2017 Recruiting --> Active, not recruiting | N=150 --> 222 | Trial primary completion date: Jan 2016 --> Sep 2016
- Trial completion: A Long Term Follow up of Anterior Meshes for Recurrent Prolapse (clinicaltrials.gov) - Mar 22, 2016
P=N/A, N=50, Completed, Sponsor: Medway NHS Foundation Trust
Recruiting --> Active, not recruiting | N=150 --> 222 | Trial primary completion date: Jan 2016 --> Sep 2016 Recruiting --> Completed
- methotrexate IV / Generic mfg.
New trial: The Impact of Salpingectomy and Single Dose Systemic Methotrexate Treatments on Ovarian Reserve in Ectopic Pregnancy (clinicaltrials.gov) - Mar 22, 2016
P=N/A, N=131, Completed, Sponsor: Ege University
- Trial primary completion date: Ensuring Communication in Hospice by Oncology Study (ECHO) (clinicaltrials.gov) - Mar 22, 2016
P=N/A, N=30, Active, not recruiting, Sponsor: Massachusetts General Hospital
Recruiting --> Completed Trial primary completion date: Dec 2015 --> May 2016
- metformin / Generic mfg.
Trial completion: Effect of Metformin on Early Pregnancy Loss in Pregnant Women With Polycystic Ovarian Syndrome (clinicaltrials.gov) - Mar 22, 2016
P0, N=166, Completed, Sponsor: Ain Shams University
Trial primary completion date: Dec 2015 --> May 2016 Recruiting --> Completed
- | Enrollment closed, Trial primary completion date: Effectiveness of IV Acetaminophen and IV Ibuprofen in Reducing Post Procedural Pain in the UFE Procedure (clinicaltrials.gov) - Mar 21, 2016
P4, N=40, Active, not recruiting, Sponsor: University of California, Los Angeles
Recruiting --> Completed Recruiting --> Active, not recruiting | Trial primary completion date: Feb 2016 --> Sep 2016
- Biomarker, New trial, IO biomarker: Standard Operating Procedures for Cervical (Pre)Cancer Biomarker Detection in First-void Urine (BM-SOP Study) (clinicaltrials.gov) - Mar 21, 2016
P=N/A, N=50, Recruiting, Sponsor: Universiteit Antwerpen
- brivanib alaninate (BMS-582664) / BMS
Trial primary completion date: Brivanib Alaninate in Treating Patients With Recurrent or Persistent Endometrial Cancer (clinicaltrials.gov) - Mar 19, 2016
P2, N=45, Active, not recruiting, Sponsor: Gynecologic Oncology Group
Recruiting --> Active, not recruiting | Trial primary completion date: Feb 2016 --> Sep 2016 Trial primary completion date: Jan 2015 --> Jan 2014
- metformin / Generic mfg.
Trial primary completion date: A Randomized Pilot Study to Evaluate the Effects of a Short Course of Metformin Versus No Therapy in the Period Prior to Hysterectomy for Grade 1-2 Adenocarcinoma of the Endometrium in Obese Non-Diabetic Women (clinicaltrials.gov) - Mar 18, 2016
P2, N=40, Recruiting, Sponsor: University of Arkansas
Trial primary completion date: Jan 2015 --> Jan 2014 Trial primary completion date: Jun 2016 --> Jun 2017
- Biomarker, Trial primary completion date: Biomarkers in Patients With Previously Untreated Invasive Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer (clinicaltrials.gov) - Mar 18, 2016
P=N/A, N=39, Active, not recruiting, Sponsor: Gynecologic Oncology Group
Trial primary completion date: Jun 2016 --> Jun 2017 Trial primary completion date: Sep 2015 --> Jan 2100
- Sancuso (granisetron) / Solasia
Trial suspension, Trial primary completion date: Granisetron, Aprepitant, and Dexamethasone in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy for Stage II, III, or IV Ovarian Cancer (clinicaltrials.gov) - Mar 18, 2016
P=N/A, N=4, Suspended, Sponsor: Gynecologic Oncology Group
Trial primary completion date: Sep 2015 --> Jan 2100 Completed --> Suspended | Trial primary completion date: Mar 2013 --> May 2014
- ||| Avastin (bevacizumab) / Roche
Trial completion, Trial primary completion date: ENCOURAGE: First Line Ovarian Cancer Treatment - Cohort Study (clinicaltrials.gov) - Mar 18, 2016
P=N/A, N=500, Completed, Sponsor: ARCAGY/ GINECO GROUP
Completed --> Suspended | Trial primary completion date: Mar 2013 --> May 2014 Recruiting --> Completed | Trial primary completion date: Jan 2017 --> Feb 2015
- buparlisib (AN2025) / Adlai Nortye
Trial completion, Enrollment change, Monotherapy, Surgery, Metastases: ENDOPIK: GINECO-EN102b - BKM120 as Monotherapy in the Treatment of Initial or Recurrent Metastatic Endometrial Cancer (clinicaltrials.gov) - Mar 18, 2016
P2, N=24, Completed, Sponsor: ARCAGY/ GINECO GROUP
Recruiting --> Completed | Trial primary completion date: Jan 2017 --> Feb 2015 Active, not recruiting --> Completed | N=56 --> 24
- carboplatin / Generic mfg., lenalidomide / Generic mfg.
Trial completion, Combination therapy: A 2 Stage Trial of Lenalidomide (REV) in Asymptomatic Ovarian Cancer Patients With Increasing CA 125 in Late Relapse (clinicaltrials.gov) - Mar 18, 2016
P2, N=67, Completed, Sponsor: ARCAGY/ GINECO GROUP
Active, not recruiting --> Completed | N=56 --> 24 Active, not recruiting --> Completed
- sildenafil / Generic mfg., clomifene citrate / Generic mfg.
New trial: Sildenafil Vaginal Gel Co-treatment With Clomiphene Citrate in Infertile Women With Thin Endometrium (clinicaltrials.gov) - Mar 18, 2016
P=N/A, N=42, Completed, Sponsor: Assiut University